BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25899053)

  • 1. Breast Cancer Detection by B7-H3-Targeted Ultrasound Molecular Imaging.
    Bachawal SV; Jensen KC; Wilson KE; Tian L; Lutz AM; Willmann JK
    Cancer Res; 2015 Jun; 75(12):2501-9. PubMed ID: 25899053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of Affibody-Based Ultrasound Molecular Imaging of Vascular B7-H3 for Breast Cancer Detection.
    Bam R; Lown PS; Stern LA; Sharma K; Wilson KE; Bean GR; Lutz AM; Paulmurugan R; Hackel BJ; Dahl J; Abou-Elkacem L
    Clin Cancer Res; 2020 May; 26(9):2140-2150. PubMed ID: 31924738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectroscopic Photoacoustic Molecular Imaging of Breast Cancer using a B7-H3-targeted ICG Contrast Agent.
    Wilson KE; Bachawal SV; Abou-Elkacem L; Jensen K; Machtaler S; Tian L; Willmann JK
    Theranostics; 2017; 7(6):1463-1476. PubMed ID: 28529630
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection and Characterization of Sentinel Lymph Node by Ultrasound Molecular Imaging with B7-H3-Targeted Microbubbles in Orthotopic Breast Cancer Model in Mice.
    Hu Z; Bachawal SV; Li X; Wang H; Wilson KE; Li P; Paulmurugan R
    Mol Imaging Biol; 2022 Apr; 24(2):333-340. PubMed ID: 34787812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative Resection Guidance with Photoacoustic and Fluorescence Molecular Imaging Using an Anti-B7-H3 Antibody-Indocyanine Green Dual Contrast Agent.
    Wilson KE; Bachawal SV; Willmann JK
    Clin Cancer Res; 2018 Aug; 24(15):3572-3582. PubMed ID: 29712688
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis and Evaluation of Clinically Translatable Targeted Microbubbles Using a Microfluidic Device for In Vivo Ultrasound Molecular Imaging.
    Bam R; Natarajan A; Tabesh F; Paulmurugan R; Dahl JJ
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular imaging of T cell co-regulator factor B7-H3 with
    Burvenich IJG; Parakh S; Lee FT; Guo N; Liu Z; Gan HK; Rigopoulos A; O'Keefe GJ; Gong SJ; Goh YW; Tochon-Danguy H; Scott FE; Kotsuma M; Hirotani K; Senaldi G; Scott AM
    Theranostics; 2018; 8(15):4199-4209. PubMed ID: 30128047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent.
    Abou-Elkacem L; Wilson KE; Johnson SM; Chowdhury SM; Bachawal S; Hackel BJ; Tian L; Willmann JK
    Theranostics; 2016; 6(11):1740-52. PubMed ID: 27570547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Metastatic and Reactive Sentinel Lymph Nodes with B7-H3-Targeted Ultrasound Molecular Imaging: A Longitudinal Study in Mouse Models.
    Zheng F; Li P; Bachawal SV; Wang H; Li C; Yuan W; Huang B; Paulmurugan R
    Mol Imaging Biol; 2020 Aug; 22(4):1003-1011. PubMed ID: 32034623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model.
    Lutz AM; Bachawal SV; Drescher CW; Pysz MA; Willmann JK; Gambhir SS
    Clin Cancer Res; 2014 Mar; 20(5):1313-22. PubMed ID: 24389327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affibody-Indocyanine Green Based Contrast Agent for Photoacoustic and Fluorescence Molecular Imaging of B7-H3 Expression in Breast Cancer.
    Bam R; Laffey M; Nottberg K; Lown PS; Hackel BJ; Wilson KE
    Bioconjug Chem; 2019 Jun; 30(6):1677-1689. PubMed ID: 31082216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
    Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
    Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound molecular imaging as a non-invasive companion diagnostic for netrin-1 interference therapy in breast cancer.
    Wischhusen J; Wilson KE; Delcros JG; Molina-Peña R; Gibert B; Jiang S; Ngo J; Goldschneider D; Mehlen P; Willmann JK; Padilla F
    Theranostics; 2018; 8(18):5126-5142. PubMed ID: 30429890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B7-H3 expression in ductal and lobular breast cancer and its association with IL-10.
    Liu C; Liu J; Wang J; Liu Y; Zhang F; Lin W; Gao A; Sun M; Wang Y; Sun Y
    Mol Med Rep; 2013 Jan; 7(1):134-8. PubMed ID: 23128494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of B7-H3 in cancer tissue during osteosarcoma progression in nude mice.
    Yin SJ; Wang WJ; Zhang JY
    Genet Mol Res; 2015 Nov; 14(4):14253-61. PubMed ID: 26600483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
    Kim GE; Kim NI; Park MH; Lee JS
    Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of B7-H3 reduces the glycolytic capacity and sensitizes breast cancer cells to AKT/mTOR inhibitors.
    Nunes-Xavier CE; Karlsen KF; Tekle C; Pedersen C; Øyjord T; Hongisto V; Nesland JM; Tan M; Sahlberg KK; Fodstad Ø
    Oncotarget; 2016 Feb; 7(6):6891-901. PubMed ID: 26771843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis.
    Brunner A; Hinterholzer S; Riss P; Heinze G; Brustmann H
    Gynecol Oncol; 2012 Jan; 124(1):105-11. PubMed ID: 21982044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulatory Protein B7-H3 Reprograms Glucose Metabolism in Cancer Cells by ROS-Mediated Stabilization of HIF1α.
    Lim S; Liu H; Madeira da Silva L; Arora R; Liu Z; Phillips JB; Schmitt DC; Vu T; McClellan S; Lin Y; Lin W; Piazza GA; Fodstad O; Tan M
    Cancer Res; 2016 Apr; 76(8):2231-42. PubMed ID: 27197253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants.
    Dondero A; Morini M; Cangelosi D; Mazzocco K; Serra M; Spaggiari GM; Rotta G; Tondo A; Locatelli F; Castellano A; Scuderi F; Sementa AR; Eva A; Conte M; Garaventa A; Bottino C; Castriconi R
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33795387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.